Fig. 4From: The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot studyThe levels of serum novel biomarkers in both CRRT responders (n = 10) and non-responders (n = 7). A LRG1, B LYZ, (C) CD14, D SELL, E FMOD, F SERPINA3. * indicates P < 0.05Back to article page